P. Strome

Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

Kevin F. Jones, R. Jordan, D. Hruby, 2008, Antimicrobial Agents and Chemotherapy.

Characterization of cytotoxic cells in mice rendered neonatally tolerant of MHC alloantigens: evidence for repertoire modification.

J. Streilein, P. Wood, P. Strome, 1987, Journal of immunology.

Susceptibility of Allo-Ia Specific T Lymphocytes to Unresponsiveness in Neonatal Tolerance

K. Mohler, R. Gruchalla, J. Streilein, 1983 .

Clonal analysis of helper and effector T-Cell function in neonatal transplantation tolerance: Clonal deletion of helper cells determines lack of in vitro responsiveness

J. Streilein, P. Wood, P. Strome, 2004, Immunogenetics.

ACTIVE CLONAL DELETION IN NEONATAL H‐2 TOLERANCE *

R. Gruchalla, J. Streilein, P. Wood, 1982, Annals of the New York Academy of Sciences.

Modification of monoclonal antibody carbohydrates by oxidation, conjugation, or deoxymannojirimycin does not interfere with antibody effector functions

H. Axelrod, M. Awwad, S. Gilman, 2005, Cancer Immunology, Immunotherapy.

Failure of in vitro assays to predict accurately the existence of neonatally induced H-2 tolerance.

J. Streilein, P. Wood, P. Strome, 1989, Transplantation.

Neonatal transplantation tolerance results from two types of suppression acting during induction and at the effector phase.

R. Gruchalla, J. Streilein, P. Strome, 1981, Transplantation proceedings.